Free Design Audit Available - Click Here for Details

CeQur wins FDA nod for mealtime insulin delivery device

Each patch now replaces up to 12 mealtime injections, equaling more than 1,000 fewer injections annually, according to a news release.

CeQur announced recently that the FDA granted 510(k) clearance for its Simplicity system for an extended wear duration.

Clearance extends the wear time for the wearable mealtime insulin delivery patch from three to four days. It marks a significant advancement for what the company says is the longest wearable insulin delivery patch, which provides diabetes discretion, additional convenience and injection-free dosing.

Each patch now replaces up to 12 mealtime injections, equaling more than 1,000 fewer injections annually, according to a news release.

Sign up for Blog Updates